- Home
- Publications
- Publication Search
- Publication Details
Title
Review on Current Status of Echinocandins Use
Authors
Keywords
-
Journal
Antibiotics-Basel
Volume 9, Issue 5, Pages 227
Publisher
MDPI AG
Online
2020-05-04
DOI
10.3390/antibiotics9050227
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates: SENTRY Program 2016-2018
- (2020) Michael A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to
- (2020) Emmanuel Roilides et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- EUCAST reference testing of rezafungin susceptibility: impact of choice of plastic plates
- (2019) Maiken Cavling Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of ibrexafungerp, a novel glucan synthase inhibitor against Candida glabrata isolates with FKS mutations
- (2019) Natalie S. Nunnally et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- FKS2 and FKS3 Genes of Opportunistic Human Pathogen Candida albicans Influence Echinocandin Susceptibility
- (2018) Sumanun Suwunnakorn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of the Antifungal Activity of the Novel Oral Glucan Synthase Inhibitor SCY-078, Singly and in Combination, for the Treatment of Invasive Aspergillosis
- (2018) M. Ghannoum et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST method
- (2018) M.C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris
- (2018) Elizabeth L. Berkow et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance
- (2018) Anuradha Chowdhary et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model
- (2018) Christopher L Hager et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Prospective, Open-label Study to Assess the Safety, Tolerability, and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children 2 to
- (2018) Emmanuel Roilides et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- CD101, a long-acting echinocandin, and comparator antifungal agents tested against a global collection of invasive fungal isolates in the SENTRY 2015 Antifungal Surveillance Program
- (2017) Michael A. Pfaller et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Candida auris : An emerging multidrug-resistant pathogen
- (2017) David Sears et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis
- (2017) Dina A. Boikov et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally
- (2017) Anuradha Chowdhary et al. PLoS Pathogens
- Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin
- (2016) Voon Ong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Characterization ofIn VitroResistance Development to the Novel Echinocandin CD101 in Candida Species
- (2016) Jeffrey B. Locke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CD101, a novel echinocandin with exceptional stability properties and enhanced aqueous solubility
- (2016) B Radha Krishnan et al. JOURNAL OF ANTIBIOTICS
- Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, againstCandidaandAspergillusspp., including echinocandin- and azole-resistant isolates
- (2016) Michael A. Pfaller et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Multidrug-resistant Candida auris : ‘new kid on the block’ in hospital-associated infections?
- (2016) A. Chowdhary et al. JOURNAL OF HOSPITAL INFECTION
- First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia
- (2016) Belinda Calvo et al. JOURNAL OF INFECTION
- Combination Antifungal Therapy for Invasive Aspergillosis
- (2015) Kieren A. Marr et al. ANNALS OF INTERNAL MEDICINE
- Mechanisms of echinocandin antifungal drug resistance
- (2015) David S. Perlin Annals of the New York Academy of Sciences
- Calcium-Mediated Induction of Paradoxical Growth following Caspofungin Treatment Is Associated with Calcineurin Activation and Phosphorylation in Aspergillus fumigatus
- (2015) Praveen R. Juvvadi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Caspofungin Treatment of Aspergillus fumigatus Results in ChsG-Dependent Upregulation of Chitin Synthesis and the Formation of Chitin-Rich Microcolonies
- (2015) Louise A. Walker et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid Development of Candida krusei Echinocandin Resistance during Caspofungin Therapy
- (2015) A. Forastiero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rate ofFKSMutations among Consecutive Candida Isolates Causing Bloodstream Infection
- (2015) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris
- (2015) Sharanya Chatterjee et al. BMC GENOMICS
- Echinocandins: The Expanding Antifungal Armamentarium
- (2015) Daniel Aguilar-Zapata et al. CLINICAL INFECTIOUS DISEASES
- Echinocandin Resistance in Candida
- (2015) David S. Perlin CLINICAL INFECTIOUS DISEASES
- Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes
- (2015) Jessica C. Song et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Clinical perspectives on echinocandin resistance among Candida species
- (2015) Ryan K. Shields et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies
- (2015) Issam I. Raad et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antifungal drug resistance amongCandidaspecies: mechanisms and clinical impact
- (2015) Maurizio Sanguinetti et al. MYCOSES
- Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin
- (2014) Fernando César Bizerra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia
- (2014) N. D. Beyda et al. CLINICAL INFECTIOUS DISEASES
- Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management
- (2014) David S. Perlin DRUGS
- Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?
- (2014) A. Fekkar et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections
- (2014) Mariana Castanheira et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Phylogeny of the Clinically Relevant Species of the Emerging Fungus Trichoderma and Their Antifungal Susceptibilities
- (2014) M. Sandoval-Denis et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Development of echinocandin-resistantCandida albicanscandidemia following brief prophylactic exposure to micafungin therapy
- (2014) M.A. Ruggero et al. Transplant Infectious Disease
- Role of Matrix β-1,3 Glucan in Antifungal Resistance of Non-albicans Candida Biofilms
- (2013) K. F. Mitchell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Enfumafungin Derivative MK-3118 Shows IncreasedIn VitroPotency against Clinical Echinocandin-Resistant Candida Species and Aspergillus Species Isolates
- (2013) Cristina Jiménez-Ortigosa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
- (2013) Barbara D. Alexander et al. CLINICAL INFECTIOUS DISEASES
- In vitro antifungal susceptibility and molecular identity of 99 clinical isolates of the opportunistic fungal genus Curvularia
- (2013) Keith C. da Cunha et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Discovery and development of first in class antifungal caspofungin (CANCIDAS®)—A case study
- (2013) James M. Balkovec et al. NATURAL PRODUCT REPORTS
- Changes in Incidence and Antifungal Drug Resistance in Candidemia: Results From Population-Based Laboratory Surveillance in Atlanta and Baltimore, 2008-2011
- (2012) A. A. Cleveland et al. CLINICAL INFECTIOUS DISEASES
- ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
- (2012) O.A. Cornely et al. CLINICAL MICROBIOLOGY AND INFECTION
- EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*
- (2012) Maiken C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- Hidden Killers: Human Fungal Infections
- (2012) G. D. Brown et al. Science Translational Medicine
- Current perspectives on echinocandin class drugs
- (2011) David S Perlin Future Microbiology
- Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis
- (2011) C. F. Neoh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- First Three Reported Cases of Nosocomial Fungemia Caused by Candida auris
- (2011) Wee Gyo Lee et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance
- (2011) Ronen Ben-Ami et al. JOURNAL OF INFECTIOUS DISEASES
- Combined Therapy of Voriconazole and Anidulafungin in Murine Infections by Aspergillus flavus
- (2011) Enrique Calvo et al. MYCOPATHOLOGIA
- Echinocandins in Children
- (2011) Jill A. Hoffman et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains
- (2010) M. Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Differential Aspergillus lentulus Echinocandin Susceptibilities Are Fksp Independent
- (2010) J. F. Staab et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Echinocandins: A ray of hope in antifungal drug therapy
- (2010) NeetaD Grover INDIAN JOURNAL OF PHARMACOLOGY
- Spectrum of Clinically Relevant Acremonium Species in the United States
- (2010) H. Perdomo et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Evaluation of the Etest method for susceptibility testing ofAspergillusspp. andFusariumspp. to three echinocandins
- (2010) A. I. Martos et al. MEDICAL MYCOLOGY
- Echinocandin Antifungal Drug Resistance in Candida Species: A Cause for Concern?
- (2010) Maurizio Sanguinetti et al. Current Infectious Disease Reports
- Echinocandins: The Newest Class of Antifungals
- (2009) Allana J Sucher et al. ANNALS OF PHARMACOTHERAPY
- Fungal echinocandin resistance
- (2009) Louise A. Walker et al. FUNGAL GENETICS AND BIOLOGY
- Candida aurissp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital
- (2009) Kazuo Satoh et al. MICROBIOLOGY AND IMMUNOLOGY
- Prophylaxis With Caspofungin for Invasive Fungal Infections in High-Risk Liver Transplant Recipients
- (2009) Jesus Fortún et al. TRANSPLANTATION
- Economic analysis of micafungin versus liposomal amphotericin B for treatment of candidaemia and invasive candidiasis in Germany
- (2008) O. A. Cornely et al. CURRENT MEDICAL RESEARCH AND OPINION
- Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance
- (2008) Leah E. Cowen et al. EUKARYOTIC CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started